Chemotherapy-free regimens in frontline follicular lymphoma Editorial


Author: Batlevi, C. L.
Title: Chemotherapy-free regimens in frontline follicular lymphoma
Keywords: treatment response; overall survival; lenalidomide; constipation; drug tolerability; neutropenia; cancer combination chemotherapy; diarrhea; drug dose reduction; drug efficacy; drug withdrawal; nonhuman; risk benefit analysis; rituximab; follow up; antigen expression; cancer immunotherapy; progression free survival; editorial; drug cost; cancer regression; humoral immunity; follicular lymphoma; complement dependent cytotoxicity; phase 2 clinical trial (topic); multicenter study (topic); overall response rate; diffuse large b cell lymphoma; maintenance chemotherapy; g1 phase cell cycle checkpoint; infusion related reaction; follicular lymphoma international prognostic index; human; obinutuzumab; monoclonal antibody therapy
Journal Title: Blood
Volume: 139
Issue: 15
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-04-14
Start Page: 2263
End Page: 2264
Language: English
DOI: 10.1182/blood.2021015120
PUBMED: 35420687
PROVIDER: scopus
DOI/URL:
Notes: Editorial -- Export Date: 2 May 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Connie Wing-Ching Lee Batlevi
    176 Batlevi